Thursday was an anticlimactic day with the market waiting on a result from the vote on President Trump's healthcare bill, only to hear that the vote would be delayed. The President has now threatened to leave the current Obamacare in place and move on with tax reform if the healthcare bill is not supported today. US durable goods ahead. read report
Next 24 hours: Pound Gets Boost from UK Retail Sales
The trend against the US Dollar has been quite prominent over the past several days, though the market has reached a point where it looks to be taking time to reassess now that we’ve seen this extended period of Dollar weakness. Clearly, the fact that the Euro is testing important resistance is also factoring into more caution. read report
Next 24 hours: Yen Strength Stands Out on Wednesday
Special report: Obamacare Repeal and FX Impact
Over the course of the past several days, the US Dollar has been hit hard on a more dovish Fed and concern over Trump administration policies. At the same time, the Euro has benefited from talk about an unwinding of QE and diffused French election risk, while the Pound has surged on a surprising hawkish BOE dissent and hot inflation data. read report
Next 24 hours: US Dollar Struggling to Catch a Bid
Though most currencies were either up or sideways against the US Dollar on Monday, the Pound could not fall in line and was back under pressure, relatively underperforming. Today, UK economic data comes front and centre with CPI standing out and the bar set quite high for this key inflation reading. read report
Next 24 hours: Sterling Underperforms on Quiet Monday
The US Dollar has picked up where it left off at the end of last week, with the Buck under pressure across the board. Setbacks have been mild thus far, though the trend against the Dollar has been clear as a day, with the market continuing to sell the currency post last Wednesday's more dovishly perceived Fed decision. read report
Any opinions, news, research, analyses, prices or other information ("information") contained on this Blog, constitutes marketing communication and it has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Further, the information contained within this Blog does not contain (and should not be construed as containing) investment advice or an investment recommendation, or an offer of, or solicitation for, a transaction in any financial instrument. LMAX Exchange has not verified the accuracy or basis-in-fact of any claim or statement made by any third parties as comments for every Blog entry.
LMAX Exchange will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information. No representation or warranty is given as to the accuracy or completeness of the above information. While the produced information was obtained from sources deemed to be reliable, LMAX Exchange does not provide any guarantees about the reliability of such sources. Consequently any person acting on it does so entirely at his or her own risk. It is not a place to slander, use unacceptable language or to promote LMAX Exchange or any other FX, Spread Betting and CFD provider and any such postings, excessive or unjust comments and attacks will not be allowed and will be removed from the site immediately.
LMAX Exchange will clearly identify and mark any content it publishes or that is approved by LMAX Exchange.
FX and CFDs are leveraged products that can result in losses exceeding your deposit. They are not suitable for everyone so please ensure you fully understand the risks involved. The information on this website is not directed at residents of the United States of America, Australia (we will only deal with Australian clients who are "wholesale clients" as defined under the Corporations Act 2001), Canada (although we may deal with Canadian residents who meet the "Permitted Client" criteria), Singapore or any other jurisdiction where FX trading and/or CFD trading is restricted or prohibited by local laws or regulations.
LMAX Limited operates a multilateral trading facility. LMAX Limited is authorised and regulated by the Financial Conduct Authority (firm registration number 509778) and is a company registered in England and Wales (number 6505809). Our registered address is Yellow Building, 1A Nicholas Road, London, W11 4AN.